Komori
Takara Bio (4974) · PolicyRestated

Adoption of IFRS 16 by an Overseas Subsidiary

First written in FY2020-Q1. 2 of 3 entries say "Restated". Latest entry: FY2020-Q3.

3entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2020-Q1 – FY2020-Q32019: 220192020: 12020
Same theme, other companies

The whole theme swung hardest in 2025: 4 of 17 companies on the "Worse" side.

106 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 177 companies compared. The sentences above are computed from all 177.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Takara Bio yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Adoption of IFRS 16 by an Overseas Subsidiary | TAKARA BIO INC. (4974) | Komori